Studies had reported that overexpression of ENO1 was related to the clinical staging of lung cancer [16]; also, it was closely associated with the tumor size and lymph node metastasis of breast cancer [19], and it had a positive relationship with the clinical stage and lymph node metastasis of pancreatic cancer [20]. Here, ENO1 is linked to breast carcinoma.